Cases & Deals

Bay City Capital fund invests in Altheos

Clients Bay City Capital Fund V

Jones Day advised Bay City Capital Fund V in connection with its purchase of $20 million of Series A Convertible Preferred Stock in a private placement by Altheos, Inc., an early-stage biopharmaceutical company. Additional investors include Atheneos Capital, Canaan Partners, Life Science Angels, and Novo A/S.